AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Patrick Matthys Erik De Clercq |
| Publication date | October 1, 2001 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |